Community lists
精选 · 医疗保健

Biotech

由 InspectStocks 整理Published 2026年10月14日19 companies0 followers

Drug developers with approved medicines, built mainly on biologic and genetic science.

借助 AI 模型分组，并经我们的编辑审核。每家公司下方的一行说明它为何在这里。

Sign in to followSign in to copy
Download image
卡片梯队
A
  • GILDGilead Sciences
    US$169.73+40.9% 1Y

    Sells medicines for HIV, liver disease and cancer

  • BIIBBiogen
    US$253.39+56.9% 1Y

    Develops and sells therapies for neurological diseases

  • NBIXNeurocrine Biosciences
    US$174.35+18.7% 1Y

    Develops and sells therapies for neurological and endocrine disorders

  • EXELExelixis
    US$70.71+62.2% 1Y

    Develops and sells cancer therapies

  • JAZZJazz Pharmaceuticals
    US$248.18+81.5% 1Y

    Develops and sells neuroscience and oncology therapies

  • HALOHalozyme Therapeutics
    US$101.69+44.0% 1Y

    Licenses drug delivery technology and sells enzyme-based therapies

  • KRYSKrystal Biotech
    US$308.82+52.1% 1Y

    Develops and sells topical gene therapies for rare diseases

  • CORTCorcept Therapeutics
    US$74.52-4.9% 1Y

    Develops and sells cortisol-modulating therapies

B
  • VRTXVertex Pharmaceuticals
    US$547.02+26.0% 1Y

    Develops and sells cystic fibrosis and other medicines

  • ALNY因增长减弱下调一级Alnylam Pharmaceuticals
    US$159.80-64.7% 1Y

    Develops and sells RNAi therapeutics

  • BBIOBridgeBio Pharma
    US$79.53+20.1% 1Y

    Develops therapies for genetic diseases

  • BMRNBioMarin Pharmaceutical
    US$58.32+5.4% 1Y

    Develops and sells therapies for rare genetic diseases

C
  • REGNRegeneron Pharmaceuticals
    US$959.45+41.5% 1Y

    Develops and sells antibody therapies for eye, allergy and cancer conditions

  • MRNAModerna
    US$248.70+831.1% 1Y

    Develops mRNA vaccines and therapies

  • INSMInsmed
    US$120.64-37.9% 1Y

    Develops and sells therapies for rare lung diseases

  • UTHR因增长减弱下调一级United Therapeutics
    US$595.58+29.0% 1Y

    Sells therapies for pulmonary arterial hypertension

  • INCYIncyte
    US$122.23+12.9% 1Y

    Develops and sells oncology and inflammation therapies

D
  • ASNDAscendis Pharma A/S
    US$259.10+30.1% 1Y

    Develops and sells endocrinology rare disease therapies

F
  • BNTXBioNTech
    US$87.64-21.5% 1Y

    Develops mRNA vaccines and cancer therapies

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.